Eddie Martucci, PhD

Eddie Martucci co-founded Akili Interactive in 2011 with the bold vision of challenging the status quo of medicine. The realization of that vision came in 2020 when Akili received FDA Clearance and CE mark approval in Europe for EndeavorRx in ADHD, making it the first and only prescription treatment delivered through a video game. Eddie is a founding Board member of the Digital Therapeutics Alliance. He is actively involved in setting standards for the industry and frequently serves as a speaker on the digital therapeutics industry and healthcare innovation. Prior to starting Akili in 2011, Eddie helped launch PureTech Health’s digital health initiative and co-founded two other health-focused start-ups. He completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry. Eddie received his B.S. in Biochemistry from Providence College, and his M.Phil. and Ph.D. from Yale University.